Annunziata S - Search Results

1

Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?

Collarino A, Feudo V, Pasciuto T, Florit A, Pfaehler E, de Summa M, Bizzarri N, Annunziata S, Zannoni GF, de Geus-Oei LF, Ferrandina G, Gambacorta MA, Scambia G, Boellaard R, Sala E, Rufini V, van Velden FH. Collarino A, et al. Among authors: annunziata s. J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044. Online ahead of print. J Nucl Med. 2024. PMID: 38548352

2

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.

Cuccaro A, Annunziata S, Cupelli E, Martini M, Calcagni ML, Rufini V, Giachelia M, Bartolomei F, Galli E, D'Alò F, Voso MT, Leone G, Giordano A, Larocca LM, Hohaus S. Cuccaro A, et al. Among authors: annunziata s. Cancer Med. 2016 Mar;5(3):398-406. doi: 10.1002/cam4.585. Epub 2016 Jan 13. Cancer Med. 2016. PMID: 26758564 Free PMC article.

3

Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).

Annunziata S, Cuccaro A, Calcagni ML, Hohaus S, Giordano A, Rufini V. Annunziata S, et al. Ann Nucl Med. 2016 Oct;30(8):588-92. doi: 10.1007/s12149-016-1092-9. Epub 2016 May 31. Ann Nucl Med. 2016. PMID: 27246952

4

Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma.

Caldarella C, Annunziata S, Pagano L, De Stefano V, Rufini V. Caldarella C, et al. Among authors: annunziata s. Clin Nucl Med. 2017 Feb;42(2):e130-e134. doi: 10.1097/RLU.0000000000001462. Clin Nucl Med. 2017. PMID: 27922862

5

Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan.

Annunziata S, Calcagni ML, Indovina L, Rufini V. Annunziata S, et al. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2140-2141. doi: 10.1007/s00259-017-3819-9. Epub 2017 Sep 6. Eur J Nucl Med Mol Imaging. 2017. PMID: 28879394 No abstract available.

6

Lung uptake of fluorine-18 fluoroethyl-choline PET-CT in patients with prostate cancer.

Pizzuto DA, Annunziata S, Ieria FP, Caldarella C, Isgrò MA, Lanni V, Bencivenga G, Rufini V, Giordano A. Pizzuto DA, et al. Among authors: annunziata s. Q J Nucl Med Mol Imaging. 2019 Dec;63(4):387-393. doi: 10.23736/S1824-4785.18.02985-0. Epub 2018 Jan 17. Q J Nucl Med Mol Imaging. 2019. PMID: 29345442

7

FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV_max (rPET).

Annunziata S, Cuccaro A, Tisi MC, Hohaus S, Rufini V. Annunziata S, et al. Ann Nucl Med. 2018 Jun;32(5):372-377. doi: 10.1007/s12149-018-1243-2. Epub 2018 Feb 20. Ann Nucl Med. 2018. PMID: 29464479

8

The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event.

Annunziata S, Pelliccioni A, Hohaus S, Maiolo E, Cuccaro A, Giordano A. Annunziata S, et al. Ann Nucl Med. 2021 Jan;35(1):102-110. doi: 10.1007/s12149-020-01542-y. Epub 2020 Oct 22. Ann Nucl Med. 2021. PMID: 33094420

9

PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma.

Cuccaro A, Bellesi S, Galli E, Zangrilli I, Corrente F, Cupelli E, Fatone F, Maiolo E, Alma E, Viscovo M, D'Alò F, Annunziata S, Martini M, Rufini V, Giordano A, De Stefano V, Larocca LM, Hohaus S. Cuccaro A, et al. Among authors: annunziata s. J Leukoc Biol. 2022 Sep;112(3):539-545. doi: 10.1002/JLB.5AB0121-041R. Epub 2022 Jan 20. J Leukoc Biol. 2022. PMID: 35060170 Free PMC article.

10

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.

Leccisotti L, Maccora D, Malafronte R, D'Alò F, Maiolo E, Annunziata S, Rufini V, Giordano A, Hohaus S. Leccisotti L, et al. Among authors: annunziata s. J Cancer Res Clin Oncol. 2023 Jul;149(7):2783-2791. doi: 10.1007/s00432-022-04138-3. Epub 2022 Jul 2. J Cancer Res Clin Oncol. 2023. PMID: 35779106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page